{"title":"Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment","link":"https://www.sciencedirect.com/science/article/pii/S2405844024084639?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: 30 June 2024</p><p><b>Source:</b> Heliyon, Volume 10, Issue 12</p><p>Author(s): Tero Ylisaukko-oja, Clas-Göran af Björkesten, Anja Eberl, Heikki Nuutinen, Airi Jussila, Pauliina Molander, Ritva Koskela, Timo Blomster, Markku Pajala, Tuire Ilus, Paula Haiko, Bianca Kovac, Saija Silvola, Sarah Smith, Jari Jokelainen, Taina Sipponen</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"b513b85cd57312d4045093d302c83a955e69f41a4b5cba6728b2d2e581cf0a9d","category":"Interdisciplinary"}